Obinutuzumab

obinutuzumab · Genentech

Drug timelines are a Plus or Pro feature.

132 regulatory and trial events tracked for Obinutuzumab, covering 2014-03-31 to 2026-06-25. Get the full timeline:

Most recent: Clinical Trial Results: Obinutuzumab in Primary FSGS [Phase 2]